Announcements Trials
Browse Landscape

Phase

Phase 2 48Phase 1 46Phase 1/2 23Phase 3 21Phase NA 10Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 12Squamous Cell Carcinoma of Head and Neck 11Prostatic Neoplasms 11Neoplasms 10Breast Neoplasms 8Stomach Neoplasms 7Recurrence 7Ovarian Neoplasms 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Head and Neck Neoplasms 7Myasthenia Gravis 6Colorectal Neoplasms 6Pancreatic Neoplasms 5Oropharyngeal Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Fatigue 5Urinary Bladder Neoplasms 4Mouth Neoplasms 4Melanoma 4Fallopian Tube Neoplasms 4Colonic Neoplasms 4Cholangiocarcinoma 4Rectal Neoplasms 3Peritoneal Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Endometrial Neoplasms 3

Interventions

atezolizumab 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Small Cell Lung Carcinoma × 90 days × Clear all
NCT07226999 2026-06-04

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Pfizer

Phase 2/3 Recruiting
550 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡